Breast cancer is the most prevalent cancer among females globally.According to statistics, there were ~2.1 million new breast cancer cases and ~63,000 breast cancer deaths in 2018 (Bray et al., 2018).Female breast cancer is also the most commonly diagnosed cancer worldwide, with 2.26 million cases having been diagnosed in 2020 (Ferlay et al., 2021). With the development of medical treatment, the 10-year survival rates among breast cancer now exceeds 90%, which has contributed to a statistically significant number of breast cancer survivors (Akechi et al., 2018). The National Coalition for Cancer Survivorship of the United States regards cancer survivors as those who have undergone treatment after being diagnosed with cancer or those considered to be fully cured (Lee & Park, 2020). However, some reports about cancer survivors as those who have finished conventional therapy, such as surgery, radiotherapy and chemotherapy but includes those who have entered the follow-up period or the endocrine treatment period (Mao & Sun, 2015). In this study, we use this latter definition. Modalities of treatments for breast cancer include surgery, chemotherapy, radiation, targeted therapy and hormone therapy . After cancer treatment, some complications may persist for years, such as persistent pain (Juhl et al., 2016), breast cancer-related lymphedema (Ferguson et al., 2016), and sleep disturbance (Singer et al., 2018). Among breast cancer survivors, the